Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GLUE
SGP
Add up to 3 more stocks
GLUE
Monte Rosa Therapeutics, Inc.
-3.89%
$9.87-0.40Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$833.81M
52W Range
$7.24 - $25.77
SGP
SpyGlass Pharma, Inc. Common Stock
-3.17%
$24.78-0.81Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$828.48M
52W Range
$17.06 - $32.44
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.71 | 3.57 |
| P/S Ratio | 29.03 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 92.9% | 0.0% |
| Operating Margin | -43.8% | 0.0% |
| Net Margin | -560.9% | 0.0% |
| ROE | -33.1% | -24.1% |
| ROA | -23.1% | -23.0% |
| ROIC | -28.7% | -26.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.52 | 25.06 |
| Quick Ratio | 9.52 | 25.06 |
| Debt/Equity | 0.08 | 0.01 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.